Navigation Links
Breakthrough in cell-type analysis offers new ways to study development and disease
Date:11/13/2008

"We've created a novel, generally applicable tool that can be used by a broad spectrum of the scientific community," says Heintz, who is the James and Marilyn Simons Professor, head of the Laboratory of Molecular Biology and a Howard Hughes Medical Institute investigator. "I think it will rapidly spread into many of areas of biology."

Greengard, Vincent Astor Professor and head of the Laboratory of Molecular and Cellular Neuroscience, says about half of the research in his lab now employs the new technique to study the biochemical basis of Parkinson's, Alzheimer's and Huntington's diseases, as well as the still-mysterious ways in which psychoactive drugs fight schizophrenia and depression. TRAP should fundamentally change biochemical studies of the brain and the speed at which they yield results, he says.

"We can look at a thousand genes instead of one at a time, so things should clear a thousand times faster," says Greengard, who won the Nobel Prize in Physiology or Medicine in 2000 for research into how neurons communicate.

The TRAP method grew out of a project known as GENSAT (for Genetic Expression Nervous System Atlas) that Heintz and Rockefeller professor Mary Beth Hatten launched in 2000 to visualize the contributions of individual genes to the mouse brain. Heintz and his colleagues had developed a technique to engineer large pieces of DNA carried in bacterial artificial chromosomes (BACs), which can insinuate themselves into the genomes of other organisms. They were able to insert the genetic code for green fluorescent protein (EGFP) within the regulatory domain of any gene of interest. When one of these modified BACs is transferred into mice, expression of the EGFP mimics that of the gene of interest, lighting up cells with a green glow that shows researchers all of the cells in which that particular gene functions.

The GENSAT database laid out in glowing green myriad cell types of the mouse brain. And it provided ge
'/>"/>

Contact: Brett Norman
bnorman@rockefeller.edu
212-327-7613
Rockefeller University
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
2. drugstore.com and Revolution Health Group Announce Breakthrough Deal
3. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
4. CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency
5. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
6. Breakthrough in organ rejection diagnosis examines gene behavior
7. Safe Sex Passport Launches to Provide Breakthrough Protection Against STDs and HIV
8. Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome
9. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
10. TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007
11. California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., The National Comprehensive Cancer Network (NC...ent that details a draft paradigm for near-term co... upon existing data. The document introduces the N...sensus-based process that compares the risk-versus...d in the NCCN Clinical Practice Guidelines in Onco...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassad...USNewswire/ -- Joshua Hoffman of Weston, Fla., was...ans that doctors could not say whether he would su...ar. Today, the 6-year-old was named March of Dimes...lanie Hoffman, recalls, "My first minutes of mothe...
(Date:11/9/2009)..., NEW YORK, Nov. 9 Th...l make its world television debut on the Sundance ...8 p.m. EST/PST. ,, Directed by Academy Award&#...journeys of children with type 1 diabetes amid the...one the world,s poorest countries. The children ar...
(Date:11/9/2009)..., NEW YORK, Nov. 9 /PRNewswire/ -- Phoenix ...nd drug abuse treatment and prevention program, an...., a nationally and internationally recognized lea...Chief Clinical Officer, effective January 1, 2010.... of substance abuse treatment research and her wor...
(Date:11/9/2009)..., CAMBRIDGE, Mass., Nov. 9 Ab...d capabilities in delivering emergency management ...y awarded contracts to support the work of the Fed...f Regional Operations, the National Commission on ...itan Area Transit Authority (WMATA). The value of...
Breaking Medicine News(10 mins):Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2
...dy finds that youth populations with sickle cell d...and thus may fail to benefit from scientific advan...ncer , finds that the patients, mostly African Ame...ed blood cells, affects close to 100,000 persons i...
...sful results from use of its patented personalized..., Inc. is working on advancing the P3T family of p...T. MEDRAD will demonstrate some of these potential...ized patient injection protocols are showing promi...
...o carry same dangers, study finds , , MOND...abetes drug Avandia -- already controversial becau...r than Actos, another drug in the same class, rese...itazone), both of which are part of a class of dru...
...just talk about eating healthfully, they make heal...ssociation,s (ADA,s) Food and Culinary Professiona...st, Fresh & Flavorful" recipe contest sponsore...s were that they must include at least 2 tablespoo...
...00 square feet to top pediatric research instituti...s) November 24, 2008 -- Children,s National Medica...itute , dedicated new research facilities today, i...ic leaders from the community joined the faculty o...
...the pioneer,in applying advanced technology to emu...out the coach -- for wellness, disease management,...g well, has introduced one of its most,comprehensi...arriers that prevent them from being physically ac...
Other Medicine News:Health News:Children with sickle cell disease receiving inadequate care 2Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 2Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 3Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 4Health News:Avandia's Heart Risk Higher Than Others in Its Class 2Health News:Avandia's Heart Risk Higher Than Others in Its Class 3Health News:Avandia's Heart Risk Higher Than Others in Its Class 4Health News:Three Chef-Dietitians Win CanolaInfo Recipe Contest 2Health News:Children's National Dedicates New Research Facility 2Health News:Children's National Dedicates New Research Facility 3Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 2Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 3Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 4Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 5
(Date:11/9/2009)... TOWN OF HEMPSTEAD, N.Y., Nov. 9 /PRNewswire/ -- ...ice officers and other rescue workers came togethe...ty. Merrick firefighter Brian McCauley was one of ... save his own life. ,, Only in his late 30s, Mc...ndergone surgery and extensive chemotherapy treatm...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Women,s...t has changed its name to Viveve as it prepares fo... select U.S. markets. ,, "Viveve is a name that...cus on women,s sexual health," said Kerry Pope, Vi...ts for the sole purpose of helping women restore t...
(Date:11/9/2009)... NATICK, Mass., Nov. 9 B...nnounced the launch of its COGNIS® cardiac re...TELIGEN® implantable cardioverter defibrillat... the Japanese Ministry of Health, Labor and Welfar...oval in September. COGNIS and TELIGEN are the res...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...05, 2007 /PRNewswire/ -- Results from,the primary ...Phase,3 study showed that 77 percent of treatment-...TM) (darunavir) 600 mg tablets with,100 mg ritonav...kground regimen (OBR) of antiretroviral (ARV) agen...at week 48, compared to 68,percent of patients tak...
...INESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc....ta,from an ongoing phase II trial of ZIO-201 (isop...oma patients was presented at the,European Society...,2007 in Lugano, Switzerland. The abstract entitle...Sarcoma," was presented by,Rashmi Chugh, MD, a Pri...
Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
...efabricated foot and ankle products resolves a wid...ability to foot malalignment. Ossur products uniqu... and energy-return technology., ,Age is not impor...ot orthoses provide a measure of support, but peop...
...rigid shell with a vacuum liner used to provide su...t is a non-weight bearing splint. Once the patient...to the STORM walker boot., ,Patients requiring ma... the STORM and insert the vacuum liner from the Va...
Active Ankle Orthosis(Trainers)
Bledsoe Wee Walker Boot
Medicine Products: